脑干动静脉畸形的立体定向放射外科治疗:一项多中心研究
这项多中心研究通过国际伽玛刀研究基金会纳入6个医学中心的205例脑干动静脉畸形(bAVM)患者,评估立体定向放射外科(SRS)后的结局。中位随访69个月时总体闭塞率为65.4%,末次随访良好结局(FO)为64.4%,SRS后出血发生率为8.8%。作者结论认为SRS可使多数bAVM患者获得闭塞并避免永久性并发症。
要点
- 205例bAVM患者接受SRS,平均随访69个月,总体闭塞率65.4%,良好结局64.4%。
- 边缘剂量>20 Gy者更易获得闭塞(P=.001);SRS后出血发生率8.8%,年出血率1.5%。
- 永久性症状性放射性并发症发生率14.6%(n=30),包括长束征和新发颅神经缺损。
核心结论
- SRS治疗bAVM可使多数患者获得闭塞并避免永久性并发症。
研究设计与样本
- 多中心研究,6个医学中心通过国际伽玛刀研究基金会提供205例患者数据;中位年龄32岁(6-81岁),中位病灶体积1.4 mL(0.1-69 mL)。
主要发现
- 平均随访69个月时总体闭塞率65.4%(n=134),其中血管造影证实闭塞53.2%(n=109)、MRA证实12.2%(n=25)。
- SRS后2、3、5、7、10年的闭塞率分别为24.5%、43.3%、62.3%、73%、81.8%。
- 边缘剂量>20 Gy者更易获得闭塞(P=.001);接受更高处方边缘剂量(P=.05)和更高最大剂量(P=.041)者闭塞更早。
- SRS后出血发生率为8.8%(n=18),伽玛刀后潜伏期年出血率为1.5%;放射性并发症影像学可见35.6%(n=73)、有症状14.6%(n=30)、永久性14.6%(n=30,包括长束征和新发颅神经缺损)。
- 良好结局为64.4%(n=132);其预测因素为较高的Virginia放射外科AVM量表评分(P=.003)、既往出血(P=.045)和较低的处方最大剂量(P=.006)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The management of brainstem arteriovenous malformations (bAVMs) is a formidable challenge. bAVMs harbor higher morbidity and mortality compared to other locations. OBJECTIVE: To review the outcomes following stereotactic radiosurgery (SRS) of bAVMs in a multicenter study. METHODS: Six medical centers contributed data from 205 patients through the International Gamma Knife Research Foundation. Median age was 32 yr (6-81). Median nidus volume was 1.4 mL (0.1-69 mL). Favorable outcome (FO) was defined as AVM obliteration and no post-treatment hemorrhage or permanent symptomatic radiation-induced complications. RESULTS: Overall obliteration was reported in 65.4% (n = 134) at a mean follow-up of 69 mo. Obliteration was angiographically proven in 53.2% (n = 109) and on MRA in 12.2% (n = 25). Actuarial rate of obliteration at 2, 3, 5, 7, and 10 yr after SRS was 24.5%, 43.3%, 62.3%, 73%, and 81.8% respectively. Patients treated with a margin dose >20 Gy were more likely to achieve obliteration (P = .001). Obliteration occurred earlier in patients who received a higher prescribed margin dose (P = .05) and maximum dose (P = .041). Post-SRS hemorrhage occurred in 8.8% (n = 18). Annual postgamma knife latency period hemorrhage was 1.5%. Radiation-induced complications were radiologically evident in 35.6% (n = 73), symptomatic in 14.6% (n = 30), and permanent in 14.6% (n = 30, which included long-tract signs and new cranial nerve deficits). FO was achieved in 64.4% (n = 132). Predictors of an FO were a higher Virginia radiosurgery AVM scale score (P = .003), prior hemorrhage (P = .045), and a lower prescribed maximum dose (P = .006). CONCLUSION: SRS for bAVMs results in obliteration and avoids permanent complications in the majority of patients.
引用
- Cohen-Inbar O, Starke RM, Lee CC, et al. Stereotactic Radiosurgery for Brainstem Arteriovenous Malformations: A Multicenter Study. Neurosurgery. 2017. PMID: 28645182. doi:10.1093/neuros/nyx189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。